2025-04-07 (一) 19:00 ~ 20:50

This event will gather experts across Asia Pacific, aiming to discuss the current state and potential applications of atezolizumab in extensive-stage small cell lung cancer (ES-SCLC) management. Objectives Highlight the latest 6-year overall survival data on atezolizumab and the implications on clinical practice Showcase real-world evidence on: The applications of atezolizumab in the management of ES-SCLC The clinical benefits of the subcutaneous formulation of atezolizumab compared with the standard intravenous administration